CDT
Conduit Pharmaceuticals Inc: Partners With Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
时间：2025-02-13 21:01:29 市场： 美股 综合
Conduit Pharmaceuticals: Study to Accelerate Development of Azd1656 for Autoimmune Disorders, Focus on Systemic Lupus Erythematosus, Lupus Nephritis
时间：2025-02-13 21:01:29 市场： 美股 综合
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
时间：2025-02-11 22:00:04 市场： 美股 综合
Conduit Pharmaceuticals Transitions to Phase Ii of Sarborg Collaboration to Support AI-Driven Drug Development
时间：2025-02-07 21:00:00 市场： 美股 综合
Conduit Pharmaceuticals Completes Strategic Review With Sarborg to Map Revolutionizing Drug Development With Artificial Intelligence
时间：2025-01-28 18:30:00 市场： 美股 综合
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
时间：2024-12-12 20:30:00 市场： 美股 综合
Venrock Healthcare Capital Partners Iii Lp Reports 9.99% Passive Stake in Cidara Therapeutics Inc as of November 26 - SEC Filing
时间：2024-12-05 05:20:36 市场： 美股 综合
Cidara Therapeutics Announces $105 Million Private Placement
时间：2024-11-21 21:30:43 市场： 美股 综合
Conduit Pharmaceuticals Receives Further Patent Approval for Lead Asset Targeting Autoimmune Disorders
时间：2024-11-21 20:30:39 市场： 美股 综合
Cidara Therapeutics Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $33
时间：2024-11-08 20:22:39 市场： 综合 美股